264 related articles for article (PubMed ID: 22329470)
1. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
[TBL] [Abstract][Full Text] [Related]
2. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
Citrome L
Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
[TBL] [Abstract][Full Text] [Related]
4. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
Citrome L
Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
[TBL] [Abstract][Full Text] [Related]
5. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
Lesem MD; Tran-Johnson TK; Riesenberg RA; Feifel D; Allen MH; Fishman R; Spyker DA; Kehne JH; Cassella JV
Br J Psychiatry; 2011 Jan; 198(1):51-8. PubMed ID: 21200077
[TBL] [Abstract][Full Text] [Related]
6. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Vieta E
BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
[TBL] [Abstract][Full Text] [Related]
8. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
[TBL] [Abstract][Full Text] [Related]
9. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy review of inhaled loxapine for treatment of agitation.
Currier G; Walsh P
Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):25-32. PubMed ID: 23538290
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
[TBL] [Abstract][Full Text] [Related]
12. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.
Keating GM
CNS Drugs; 2013 Jun; 27(6):479-89. PubMed ID: 23740380
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular aripiprazole in the control of agitation.
Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
[TBL] [Abstract][Full Text] [Related]
14. Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
Pollack CV
Curr Med Res Opin; 2016 Jul; 32(7):1253-60. PubMed ID: 27121764
[TBL] [Abstract][Full Text] [Related]
15. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
Owen RT
Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
[TBL] [Abstract][Full Text] [Related]
16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
17. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
de Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; Valchera A; Carano A; Vellante F; Marini S; Piersanti M; Perna G; Martinotti G; Di Giannantonio M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208695
[TBL] [Abstract][Full Text] [Related]
18. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
